Form4.ai tracks every SEC insider trade in real time. See every SKYE insider filing with a free account — no card.
See every SKYE insider filing — free account, no card.
Free accountSkye Bioscience, Inc. (SKYE) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 6 sales totalling $889K. Most recent filing: Sept. 24, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 24, 2026 SEC filing | Schwab Andrew J. Director Same trade as 5AM Partners VII, LLC | Sold | $239,555 | — |
| Sep 18, 2026 SEC filing | Schwab Andrew J. Director Same trade as 5AM Partners VII, LLC | Sold | $64,734 | — |
| Aug 20, 2026 SEC filing | Schwab Andrew J. Director Same trade as 5AM Partners VII, LLC | Sold | $140,313 | — |
Create a free account to see all 7 SKYE filings from the last 90 days. No card needed.
Create free accountWant SKYE insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.